Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × apixaban × Classical hematology × Clear all

Phase

Phase 3 5 Phase 2 4 Phase NA 2 Phase 4 2 Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thrombosis 1 Thromboembolism 1 Thrombocytopenia 1 Pulmonary Embolism 1

Interventions

siltuximab 1 decitabine and cedazuridine drug combination 1 daratumumab 1 apixaban 1 Transplantation 1 Simvastatin 1 Observation 1 Cord Blood Stem Cell Transplantation 1 Biopsy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06886516 2025-03-20

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Recruiting

Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡